Hepatitis B Immune Globulin (NIDDK)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHepatitis B Immune Globulin (NIDDK)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe National Institute Of Diabetes And Digestive And Kidney Diseases
China Registration ClassN/A

Develop Information

Active CompaniesThe National Institute Of Diabetes And Digestive And Kidney Diseases
Inactive CompaniesNational Institute Of Diabetes And Digestive And Kidney Diseases
Active IndicationsHepatitis B
Inactive IndicationsHepatitis B, Chronic

Other Information

ATC CodeN/A
Related LinksN/A